For the month ended 31 March 2026, Sinohealth Technology Holdings Limited reported no movements in either authorised or issued share capital, according to its monthly return filed with Hong Kong Exchanges and Clearing Limited on 9 April 2026.
Authorised Share Capital • Authorised share count remained at 2.00 billion ordinary shares with a par value of USD 0.01, equivalent to authorised capital of USD 20.00 million.
Issued Shares and Treasury Shares • Issued shares (excluding treasury shares) stayed at 451.77 million, with zero treasury shares on record. • No shares were issued, cancelled, repurchased, or transferred during the month.
Public Float Compliance • Shares held by the public represented 16.45 % of total issued shares, exceeding the 15 % minimum threshold required under Hong Kong Main Board Rule 13.32D(1).
Share Option Scheme Activity • No share options were exercised or cancelled in March; outstanding options remain at zero. • The scheme still allows up to 45.00 million additional shares to be granted in future awards.
Warrants, Convertibles and Other Instruments • The company reported no outstanding warrants, convertible securities, or other equity-linked instruments.
Overall, Sinohealth Tech’s share capital structure and public float position were unchanged during March 2026, with full compliance confirmed under the Exchange Listing Rules.
Comments